AC IMMUNE SA SF-02 Capital Reinvestment Ratio
AC IMMUNE SA SF-02 capital reinvestment ratio. AC IMMUNE SA SF-02 (IMR) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow (€5.93 Million) in capital expenditures (€90.00K). Check AC IMMUNE SA SF-02 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AC IMMUNE SA SF-02 (2024–2024)
Capital reinvestment ratio of AC IMMUNE SA SF-02 from 2024 to 2024. This chart tracks AC IMMUNE SA SF-02's Capital Reinvestment Ratio across 1 annual periods. Also explore AC IMMUNE SA SF-02 (IMR) net asset momentum to track the company's year-over-year net asset growth rate.
AC IMMUNE SA SF-02 Capital Reinvestment Ratio by Year (2024–2024)
AC IMMUNE SA SF-02 capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see AC IMMUNE SA SF-02 cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | €65.84 Million | €576.00K | — |